Cargando…

Induced Pluripotent Stem Cells: Hope in the Treatment of Diseases, including Muscular Dystrophies

Induced pluripotent stem (iPS) cells are laboratory-produced cells that combine the biological advantages of somatic adult and stem cells for cell-based therapy. The reprogramming of cells, such as fibroblasts, to an embryonic stem cell-like state is done by the ectopic expression of transcription f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gois Beghini, Daniela, Iwao Horita, Samuel, Cascabulho, Cynthia Machado, Anastácio Alves, Luiz, Henriques-Pons, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432218/ https://www.ncbi.nlm.nih.gov/pubmed/32751747 http://dx.doi.org/10.3390/ijms21155467

Ejemplares similares

A Promising Future for Stem-Cell-Based Therapies in Muscular Dystrophies—In Vitro and In Vivo Treatments to Boost Cellular Engraftment
por: Gois Beghini, Daniela, et al.
Publicado: (2019)

Mesenchymal Stem Cells in the Treatment of COVID-19, a Promising Future
por: Beghini, Daniela Gois, et al.
Publicado: (2021)

In the presence of Trypanosoma cruzi antigens, activated peripheral T lymphocytes retained in the liver induce a proinflammatory phenotypic and functional shift in intrahepatic T lymphocyte
por: Meuser‐Batista, Marcelo, et al.
Publicado: (2020)

After Experimental Trypanosoma cruzi Infection, Dying Hepatic CD3(+)TCRαβ(+)B220(+) T Lymphocytes Are Rescued from Death by Peripheral T Cells and Become Activated
por: Vacani-Martins, Natalia, et al.
Publicado: (2020)

Pulmonary Mesenchymal Stem Cells in Mild Cases of COVID-19 Are Dedicated to Proliferation; In Severe Cases, They Control Inflammation, Make Cell Dispersion, and Tissue Regeneration
por: Henriques-Pons, Andrea, et al.
Publicado: (2022)

Induced Pluripotent Stem Cells for Duchenne Muscular Dystrophy Modeling and Therapy
por: Danisovic, Lubos, et al.
Publicado: (2018)

Human induced pluripotent stem cell models for the study and treatment of Duchenne and Becker muscular dystrophies
por: Piga, Daniela, et al.
Publicado: (2019)

Evaluating a Stone of Hope: ICER’s 2019 Review of Treatments for Duchenne Muscular Dystrophy
por: Brandsema, John Frederick
Publicado: (2020)

Can Human Pluripotent Stem Cell-Derived Cardiomyocytes Advance Understanding of Muscular Dystrophies?
por: Kalra, Spandan, et al.
Publicado: (2016)

Duchenne’s Muscular Dystrophy: The Role of Induced Pluripotent Stem Cells and Genomic Editing on Muscle Regeneration
por: May, Vanessa, et al.
Publicado: (2020)

Induced pluripotent stem cells derived cardiomyocytes from Duchenne Muscular Dystrophy patients in vitro
por: Ghori, Fareeha Faizan, et al.
Publicado: (2021)

Modeling Duchenne Muscular Dystrophy Cardiomyopathy with Patients’ Induced Pluripotent Stem-Cell-Derived Cardiomyocytes
por: Eisen, Binyamin, et al.
Publicado: (2023)

The Duchenne muscular dystrophy gene and cancer
por: Jones, Leanne, et al.
Publicado: (2020)

An ex vivo Gene Therapy Approach to Treat Muscular Dystrophy Using inducible Pluripotent Stem Cells
por: Filareto, Antonio, et al.
Publicado: (2013)

Early pathogenesis of Duchenne muscular dystrophy modelled in patient-derived human induced pluripotent stem cells
por: Shoji, Emi, et al.
Publicado: (2015)

Effect of benznidazole on cerebral microcirculation during acute Trypanosoma cruzi infection in mice
por: Gonzaga, Beatriz Matheus Souza, et al.
Publicado: (2022)

Differential Requirement for Utrophin in the Induced Pluripotent Stem Cell Correction of Muscle versus Fat in Muscular Dystrophy Mice
por: Beck, Amanda J., et al.
Publicado: (2011)

Enhanced Reprogramming Efficiency and Kinetics of Induced Pluripotent Stem Cells Derived from Human Duchenne Muscular Dystrophy
por: Teotia, Pooja, et al.
Publicado: (2015)

Electrophysiological abnormalities in induced pluripotent stem cell‐derived cardiomyocytes generated from Duchenne muscular dystrophy patients
por: Eisen, Binyamin, et al.
Publicado: (2019)

Saying NO to muscular dystrophy
por: Dove, Alan W.
Publicado: (2001)

Fatigue in muscular dystrophies
por: Angelini, Corrado, et al.
Publicado: (2012)

Cognitive profile of patients with facioscapulohumeral muscular dystrophy
por: dos Santos, Vanessa Brzoskowski, et al.
Publicado: (2021)

RNAseq analysis for the diagnosis of muscular dystrophy
por: Gonorazky, Hernan, et al.
Publicado: (2015)

Cardiac Dysrhythmias, Cardiomyopathy and Muscular Dystrophy in Patients with Emery-Dreifuss Muscular Dystrophy and Limb-Girdle Muscular Dystrophy Type 1B
por: Hong, Jong-Seo, et al.
Publicado: (2005)

Generation of skeletal muscle cells from embryonic and induced pluripotent stem cells as an in vitro model and for therapy of muscular dystrophies
por: Salani, Sabrina, et al.
Publicado: (2012)

Induced Pluripotent Stem Cells derived Muscle Progenitors Effectively Mitigate Muscular Dystrophy through Restoring the Dystrophin Distribution
por: Cai, Wen-Feng, et al.
Publicado: (2016)

Induction of Pluripotent Stem Cells from a Manifesting Carrier of Duchenne Muscular Dystrophy and Characterization of Their X-Inactivation Status
por: Miyagoe-Suzuki, Yuko, et al.
Publicado: (2017)

Engraftment of human induced pluripotent stem cell-derived myogenic progenitors restores dystrophin in mice with duchenne muscular dystrophy
por: He, Ruojie, et al.
Publicado: (2020)

Episomal reprogramming of Duchenne muscular dystrophy patients derived CD3(+) T cells towards induced pluripotent stem cells
por: Zehravi, Mehwish, et al.
Publicado: (2021)

Contractile Activity of Myotubes Derived from Human Induced Pluripotent Stem Cells: A Model of Duchenne Muscular Dystrophy
por: Yoshioka, Kantaro, et al.
Publicado: (2021)

Skeletal Muscle Cells Derived from Induced Pluripotent Stem Cells: A Platform for Limb Girdle Muscular Dystrophies
por: Bruge, Celine, et al.
Publicado: (2022)

Bioenergetic and Metabolic Impairments in Induced Pluripotent Stem Cell-Derived Cardiomyocytes Generated from Duchenne Muscular Dystrophy Patients
por: Willi, Lubna, et al.
Publicado: (2022)

Sarcopenia and Sarcopenic Obesity in Patients with Muscular Dystrophy
por: Merlini, Luciano, et al.
Publicado: (2014)

Longitudinal Study of Three microRNAs in Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
por: Trifunov, Selena, et al.
Publicado: (2020)

Genetic Patterns of Selected Muscular Dystrophies in the Muscular Dystrophy Surveillance, Tracking, and Research Network
por: Kang, Peter B., et al.
Publicado: (2023)

Characteristics of Japanese Patients with Becker Muscular Dystrophy and Intermediate Muscular Dystrophy in a Japanese National Registry of Muscular Dystrophy (Remudy): Heterogeneity and Clinical Variation
por: Mori-Yoshimura, Madoka, et al.
Publicado: (2018)

Comparative proteomic analyses of Duchenne muscular dystrophy and Becker muscular dystrophy muscles: changes contributing to preserve muscle function in Becker muscular dystrophy patients
por: Capitanio, Daniele, et al.
Publicado: (2020)

Speech and swallowing characteristics in patients with facioscapulohumeral muscular dystrophy
por: dos SANTOS, Vanessa Brzoskowski, et al.
Publicado: (2022)

Epilepsy Characteristics in Duchenne and Becker Muscular Dystrophies
por: Ramani, Praveen Kumar, et al.
Publicado: (2023)

Modeling and study of the mechanism of dilated cardiomyopathy using induced pluripotent stem cells derived from individuals with Duchenne muscular dystrophy
por: Lin, Bo, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3vb8qnqmdtim5uklh2fl4b89bt